|  |  | | | | IDPS (Institut de Developpement de Produits de Sante) joins Bertin Pharma Branch completing that way services proposed by SPI-Bio, Biotec Centre and Ellipse Pharmaceuticals. This new acquisition permits to reinforce Ellipse Pharmaceutical competences and resource with a comprehensive and integrated offer: from early steps in formulation and analytical development to manufacturing and distribution of clinical batches, for new biochemical entities, proteins and highly potent products. Thanks to its GMP facilities and with two GLP laboratories, Bertin Technologies pharmaceutical branch offers now access to a larger range of services: pharmaceutical development, clinical batch manufacturing, ADME/bioanalysis, pharmacology, biotransformation and biomarkers. With a current turnover over 12 M⬠for 100 people, Bertin Pharma confirm its will to become a solid partner for pharmaceutical R&D. | |  |
|
| |  | | | Paris | | September 2010, 27/28 | | Les Journées du GMP : Bioanalyse et biomarqueurs | | | | | | Paris Villepinte | | October 2010, 5/7 | | CPhI - ICSE | | | | | | Paris | | October 2010, 12/13 | | Eurobio | | | | |
|
|
